πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 22 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8841295

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8815917

DP2 antagonist and uses thereof

Panmira Pharmaceuticals, LLC Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785393

Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

Panmira Pharmaceuticals, LLC Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772495

5-lipoxygenase-activating protein inhibitor

Panmira Pharmaceuticals, LLC Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8710081

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697730

5-lipoxygenase activating protein (FLAP) inhibitor

Panmira Pharmaceuticals, LLC Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524748

Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501959

Cycloalkane[B]indole antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8497381

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426449

Aminoalkylphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8399666

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC Β· Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383654

Heterocyclic antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8378107

Heteroaryl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8362044

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338484

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247602

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242145

Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8168678

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071807

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067445

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8049015

Heteroaryl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8034826

Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted